116 related articles for article (PubMed ID: 9457985)
21. Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen.
Weaver J; McHugo JM; Clark TJ
Br J Radiol; 2005 May; 78(929):394-7. PubMed ID: 15845930
[TBL] [Abstract][Full Text] [Related]
22. The role of endovaginal ultrasonography and the value of endometrial biopsy in breast cancer patients on tamoxifen therapy.
Sivalingam N; Pathmalingam A
Singapore Med J; 1999 Jun; 40(6):402-4. PubMed ID: 10489508
[TBL] [Abstract][Full Text] [Related]
23. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
24. Villous papyraceous: an unusual cause of tamoxifen-induced postmenopausal bleeding.
Oladipo A; Mathew J
Climacteric; 2006 Jun; 9(3):234-7. PubMed ID: 16766437
[TBL] [Abstract][Full Text] [Related]
25. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy.
Piura B; Yanai-Inbar I; Rabinovich A; Zalmanov S; Goldstein J
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):57-61. PubMed ID: 10221611
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
[TBL] [Abstract][Full Text] [Related]
27. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
[TBL] [Abstract][Full Text] [Related]
28. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
[TBL] [Abstract][Full Text] [Related]
29. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
30. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
31. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
32. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
[TBL] [Abstract][Full Text] [Related]
33. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
Kuzmanov B
Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and the uterus: an old drug tested by new modalities.
Achiron R; Grisaru D; Golan-Porat N; Lipitz S
Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108
[TBL] [Abstract][Full Text] [Related]
36. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal hysteroscopic follow-up during tamoxifen treatment.
Neven P; De Muylder X; Van Belle Y; Van Hooff I; Vanderick G
Lancet; 1998 Jan; 351(9095):36. PubMed ID: 9433432
[No Abstract] [Full Text] [Related]
38. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen use in Indian women--adverse effects revisited.
Ashraf M; Biswas J; Majumdar S; Nayak S; Alam N; Mukherjee KK; Gupta S
Asian Pac J Cancer Prev; 2009; 10(4):609-12. PubMed ID: 19827879
[TBL] [Abstract][Full Text] [Related]
40. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]